Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection

A study by Kitchin, Richardson et al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant.

Detalles Bibliográficos
Autor principal: Montefiori, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922435/
https://www.ncbi.nlm.nih.gov/pubmed/35474738
http://dx.doi.org/10.1016/j.xcrm.2022.100579
_version_ 1784669520444522496
author Montefiori, David C.
author_facet Montefiori, David C.
author_sort Montefiori, David C.
collection PubMed
description A study by Kitchin, Richardson et al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant.
format Online
Article
Text
id pubmed-8922435
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89224352022-03-15 Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection Montefiori, David C. Cell Rep Med Preview A study by Kitchin, Richardson et al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant. Elsevier 2022-03-15 /pmc/articles/PMC8922435/ /pubmed/35474738 http://dx.doi.org/10.1016/j.xcrm.2022.100579 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Preview
Montefiori, David C.
Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
title Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
title_full Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
title_fullStr Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
title_full_unstemmed Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
title_short Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
title_sort enhanced immunity after ad26.cov2.s vaccine breakthrough infection
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922435/
https://www.ncbi.nlm.nih.gov/pubmed/35474738
http://dx.doi.org/10.1016/j.xcrm.2022.100579
work_keys_str_mv AT montefioridavidc enhancedimmunityafterad26cov2svaccinebreakthroughinfection

Ejemplares similares